Search
report cover1

Iron Deficiency Anemia Treatment Market “By Drug Type (Ferrous Sulphate, Ferrous Gluconate, Ferrous Fumarate, Ferric Hydroxide, Sodium Ferric Gluconate, Iron Carbohydrates And Others); By Dosage Form (Tablets, Capsules And Liquid); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Online Pharmacies) ” - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Iron Deficiency Anemia Treatment Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.

Iron Deficiency Anemia Treatment Market Analysis

According to cognizance market research the iron deficiency anemia treatment market is valued at US$ 3.75 Billion and is anticipated to reach US$ 13.4 Billion by the end of 2030 with expected to register a CAGR of 17.3% from 2023 to 2030.

iron deficiency anemia treatment market

What is Iron Deficiency Anemia Treatment?

One of the most prevalent types of anemia that develops when the body does not have enough iron is iron deficiency anemia. Low levels of healthy red blood cells are the source of anemia, a medical disease. The body’s organs receive oxygen from red blood cells (RBCs). Haemoglobin, a component of red blood cells, is made in large part by iron. Less oxygen in the organism is indicated by a haemoglobin deficit. Therefore, maintaining iron levels is crucial. The human organism requires iron for the transportation of oxygen. Consuming meals high in iron, such as meat, veggies, fruits, and grains, can help avoid it. In addition, vitamin C protects against iron deficiency anemia. Lack of iron consumption, poor iron assimilation, pregnancy, and endometriosis are some of the factors that contribute to iron deficiency anemia. Fatigue, exhaustion, rough and dry skin, tachycardia, neurocognitive failure, restless legs syndrome, trouble breathing, or pain in the upper body are signs of iron deficiency anemia.

Iron Deficiency Anemia Treatment Market Outlook

Market expansion is anticipated to be impacted by the rising incidence of iron deficiency anemia. Additionally, market trends would be impacted by the increasing incidence of chronic renal illness over the course of the forecast period. Growing healthcare expenditure, which contributes to infrastructure development, is another important element influencing the market for treating iron deficiency anemia in terms of revenue growth. The market for treatments for iron deficiency anemia is additionally anticipated to be driven by increasing discretionary income and a rise in the risk of haemodilution. Additionally, it is anticipated that an aging populace and sedentary lifestyles will fuel market income development. The industry is expanding as a result of an increase in R&D efforts. This would present favourable opportunities for the market for treating iron deficiency anemia to grow. Additionally, rising drug launches and clearances are anticipated to fuel market revenue development. Additionally, businesses are putting an emphasis on frequent clinic appointments, ideal supplement dosages, and programme monitoring in order to boost market revenue development over the projection term.

The therapy’s costly price will reduce the market’s rate of expansion. The iron-deficiency anemia treatment business will face difficulties due to a dearth of skilled workers and a weak healthcare system in developing countries. Additionally, it is anticipated that a dearth of understanding among people will act as a barrier and slow the market’s revenue development over the course of the projection period.

Segment Analysis:

The iron deficiency anemia treatment market has been segmented into drug type, dosage form, distribution channel and geography.

Based on drug type, the iron deficiency treatment market is further segmented into ferrous sulphate, ferrous gluconate, ferrous fumarate, ferric hydroxide, sodium ferric gluconate, iron carbohydrates and others. The market for iron deficiency anemia treatment was dominated by the ferrous sulphate sector, and this pattern is anticipated to last throughout the forecast period. The ferrous sulphate market is expected to grow as a result of its availability in generic form, cheap cost, and increased choice in the treatment of iron deficiency anemia.

Based on dosage form, the iron deficiency treatment market has been classified into tablets, capsules and liquid. The tablet segment is the leading one in the iron deficiency anemia treatment market because it is the most stable, inexpensive and widely available dosage form.

Based on distribution channel, the market for iron deficiency treatment is further segmented into hospital pharmacies, retail pharmacies and online pharmacies. Due to advantages like personalized prescription plans, high-quality medication, and a rise in hospital pharmacies in emerging nations, the hospital pharmacies segment ruled the market.

Geographical Analysis:

Based on geography the iron deficiency treatment market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. During the forecast period, North America is anticipated to hold a significant market position for iron deficiency anemia treatments worldwide. The market in the region is primarily being driven by the rising incidence of chronic kidney diseases and the rising patient population of iron-deficient women in North America, which has resulted in a rise in demand for treatments for iron deficiency anemia. The CDC projects that 37 million individuals in the United States, or 15% of the population, will have chronic renal disease by 2020. Additionally, 15% of women and 12% of males have CKD. Furthermore, the prevalence is higher in the nation’s 65 and senior population.

Due to the existence of local and international companies as well as the rising demand for the treatment of iron deficiency anemia in the region, the market in Europe is predicted to grow at a rapid CAGR in the near future. In the near future, the Asia Pacific market for the therapy of iron deficiency anemia is anticipated to expand quickly. During the forecast period, India and China are expected to be lucrative marketplaces for the therapy of iron deficiency anemia. Over the next few years, it is anticipated that the presence of a sizable geriatric patient group with iron deficiency and a rise in healthcare spending in these nations will drive the market in Asia Pacific.

geographical analysis

The report offers the revenue of the iron deficiency anemia treatment market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the iron deficiency anemia treatment market for the forecast period. The iron deficiency anemia treatment market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the iron deficiency anemia treatment market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the iron deficiency anemia treatment market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the iron deficiency anemia treatment market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the iron deficiency anemia treatment market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the iron deficiency anemia treatment market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the iron deficiency anemia treatment market. The subsequent section of the iron deficiency anemia treatment report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.

Iron Deficiency Anemia Treatment Market Competitive Landscape

The study provides a detailed analysis of the major participants in the global market for treating iron deficiency anemia, including the sponsors who produce the drugs and conduct the FDA clearance studies for them. The following list of companies have presence in the market:

  • Akebia Therapeutics, Inc.
  • AMAG Pharmaceuticals
  • American Regent, Inc.
  • Amgen Inc.
  • Apotex
  • Bayer Ag
  • Covis Group S.
  • Hoffmann-La Roche Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Merck & Co.
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Ltd.

Zydus’ New Drug Application (NDA) for Oxemia was approved in 2022 by the Drug Controller General of India. Chronic renal disease-related anemia is treated with Oxemia, a sublingual, small-molecule inhibitor of hypoxia-inducible factor-prolyl hydroxylase (HIF-PH). (CKD).

In 2018, the U.S. Food and Drug Administration (FDA) approved AMAG Pharmaceuticals’ Feraheme for the treatment of iron deficiency anemia in individuals who are tolerant to dietary iron therapy but do not get significantly better after taking it.

The report explores the competitive scenario of the iron deficiency anemia treatment market. Major players operating in the iron deficiency anemia treatment market have been identified and profiled for unique commercial attributes. Company overview (company description, Type portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the iron deficiency anemia treatment market report.

Segmentation:

Iron Deficiency Anemia Market, by Drug Type

  • Ferrous Sulphate
  • Ferrous Gluconate
  • Ferrous Fumarate
  • Ferric Hydroxide
  • Sodium Ferric Gluconate
  • Iron Carbohydrates
  • Others

Iron Deficiency Anemia Treatment Market, by Dosage Form

  • Tablets
  • Capsules
  • Liquid

Iron Deficiency Anemia Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Iron Deficiency Anemia Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:

slide1

Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.

slide2

Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:

slide3

Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.

slide4

slide5

 

 

Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.

slide6

 

Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.

slide7

Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:

Attribute

Description

Market Size

US$ 13.4 Billion (2030)

Compound Annual Growth Rate (CAGR)

17.30%

Base Year

2022

Forecast Period

2023-2030

Forecast Units

Value (US$ Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

Akebia Therapeutics, Inc., AMAG Pharmaceuticals, American Regent, Inc., Amgen Inc., Apotex, Bayer Ag, Covis Group S., Hoffmann-La Roche Ltd., Janssen Pharmaceuticals, Inc., Merck & Co., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd.

Key Questions Answered in Iron Deficiency Anemia Treatment Market Report

The major players operating in the iron deficiency market are Amgen Inc., F. Hoffmann-La, Roche Ltd, Novartis AG, Pfizer Inc, Janssen Pharmaceuticals, Inc., AMAG Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Covis Group S., Apotex, Akebia Therapeutics, Inc., American Regent, Inc., Bayer Ag, Merck & Co.

The increased prevalence of iron deficiency anemia, rising prevalence of chronic renal disease, rising disposable income and increase in the risk of haemodilution, growing elderly population and sedentary lifestyles are the driving factors in the iron deficiency anemia treatment market.

The high cost of the therapy, shortage of experienced personnel and a lack of healthcare infrastructure in emerging nations, lack of knowledge among individuals are some of the challenges faced by iron deficiency treatment market.

The market’s growth is being propelled by an increase in the number of R&D activities, growing medication approvals and launches.

Iron deficiency anemia treatment market is valued at US$ 3.75 Billion and is anticipated to reach US$ 13.4 Billion by the end of 2030 with expected to register a CAGR of 17.3% from 2023 to 2030.

Single User - $4,600.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
Customization
small c popup.png
Complete the form below and we'll get back to you shortly
Discount
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert